Same Indication

Memantine vs Tofacitinib

Memantine vs Tofacitinib: Overview

This comparison examines the pharmacological differences between Memantine and Tofacitinib.

Mechanism of Action

Memantine: Non-competitive NMDA receptor antagonist.

Tofacitinib: Pan-JAK inhibitor with preference for JAK1 and JAK3 blocking pro-inflammatory cytokine signaling.

Pharmacokinetics

Half-life: Memantine — 60-80 hours; Tofacitinib — 3.2 hours.

Chemical Properties

Molecular Formula: Memantine — C12H21N; Tofacitinib — C16H20N6O.

Molecular Weight: Memantine — 179.3080 g/mol; Tofacitinib — 312.3700 g/mol.

Type: Memantine — Small molecule; Tofacitinib — Small molecule.